Crosstalk between Complement and Toll-Like Receptors

被引:75
|
作者
Song, Wen-Chao [1 ,2 ]
机构
[1] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
complement; TLR; innate immunity; inflammation; cytokines; ADAPTIVE IMMUNE-RESPONSES; HEMOLYTIC-UREMIC SYNDROME; INNATE IMMUNITY; ALTERNATIVE PATHWAY; CELL-ACTIVATION; T-CELLS; SIGNAL-TRANSDUCTION; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; DROSOPHILA TOLL;
D O I
10.1177/0192623311428478
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The complement system and toll-like receptors (TLRs) are two components of innate immunity that are critical for first-line host defense. Many pathogen-associated molecular patterns activate both complement and TLRs, and recent studies in animal models have revealed a marked synergistic interaction between the two systems. In mice deficient in a membrane complement regulator, prototypical TLR ligands such as LPS, zymosan, and polyI:C caused increased systemic complement activation, which in turn led to a profound elevation of proinflammatory cytokine biosynthesis. This phenotype required interaction between complement and TLRs because complement activation alone by cobra venom factor without TLR engagement did not lead to appreciable cytokine production. The regulatory effect of complement on TLR signaling was mediated by the anaphylatoxins C5a and C3a through a receptor-dependent mechanism and involved increased mitogen-activated protein kinase and nuclear factor kappa B activation. The crosstalk between complement and TLRs may also impact adaptive immunity, for example, the differentiation of T helper 17 (Th-17) cells. Given that excessive activation of either TLR or complement has been associated with inflammatory tissue injury as occurs in sepsis and autoimmune diseases, the new insight on complement and TLR crosstalk may have therapeutic implications.
引用
收藏
页码:174 / 182
页数:9
相关论文
共 50 条
  • [41] Avian toll-like receptors
    Brownlie, Robert
    Allan, Brenda
    CELL AND TISSUE RESEARCH, 2011, 343 (01) : 121 - 130
  • [42] Toll-like receptors and sepsis
    Ishii K.J.
    Akira S.
    Current Infectious Disease Reports, 2004, 6 (5) : 361 - 366
  • [43] Toll-like receptors in the skin
    Lloyd S. Miller
    Robert L. Modlin
    Seminars in Immunopathology, 2007, 29 : 15 - 26
  • [44] Toll-like Receptors in Autoimmunity
    Fischer, Maria
    Ehlers, Marc
    YEAR IN IMMUNOLOGY 2008, 2008, 1143 : 21 - 34
  • [45] Toll-like receptors and their ligands
    Barton, GM
    Medzhitov, R
    TOLL-LIKE RECEPTOR FAMILY MEMBERS AND THEIR LIGANDS, 2002, 270 : 81 - 92
  • [46] Toll-like Receptors and Pregnancy
    Kaori Koga
    Gil Mor
    Reproductive Sciences, 2007, 14 : 297 - 299
  • [47] Toll-like receptors and cancer
    Rakoff-Nahoum, Seth
    Medzhitov, Ruslan
    NATURE REVIEWS CANCER, 2009, 9 (01) : 57 - 63
  • [48] Toll-like receptors in COPD
    Hansbro, Philip M.
    Haw, Tatt Jhong
    Starkey, Malcolm R.
    Miyake, Kensuke
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [49] Exercise and Toll-like receptors
    Gleeson, Michael
    McFarlin, Brian
    Flynn, Michael
    EXERCISE IMMUNOLOGY REVIEW, 2006, 12 : 34 - 53
  • [50] Toll-Like Receptors and Glomerulonephritis
    Wardle, E. Nigel
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2007, 18 (02) : 159 - 172